Peter J. Bungay

A comprehensive non‐clinical evaluation of the CNS penetration potential of antimuscarinic agents for the treatment of overactive bladder

Ernesto Callegari, Bimal Malhotra, Peter J. Bungay et al. · British Journal of Clinical Pharmacology · 2011 · 181 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Regulatory Roles of the N-Terminal Domain Based on Crystal Structures of Human Pyruvate Dehydrogenase Kinase 2 Containing Physiological and Synthetic Ligands ^,

T. Knoechel, Alec D. Tucker, Colin M. Robinson et al. · Biochemistry · 2005 · 106 citations

Life Sciences, Biochemistry, Molecular Biology +10

A novel selective and orally bioavailable <scp>N</scp> a <scp> _v </scp> 1.8 channel blocker, <scp>PF</scp> ‐01247324, attenuates nociception and sensory neuron excitability

C. Elizabeth Payne, Adam R. Brown, Jonathon W Theile et al. · British Journal of Pharmacology · 2015 · 101 citations · Full text

Medicine, Neurobiology, Pharmacology +14

Application of PBPK modelling in drug discovery and development at Pfizer

Hannah M. Jones, Maurice Dickins, Kuresh Youdim et al. · Xenobiotica · 2011 · 94 citations

Pharmacy, Pharmacokinetics, Pharmacology +8

The Discovery of a Potent, Selective, and Peripherally Restricted Pan-Trk Inhibitor (PF-06273340) for the Treatment of Pain

S. Skerratt, Mark D. Andrews, Sharan K. Bagal et al. · Journal of Medicinal Chemistry · 2016 · 83 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14